ANRS, Emerging Infectious Diseases: all 215 studies

Page 3 of 3. Open to participants first (38), then studies with results posted, then the rest; newest registration first within each.

• Early and Intermittent Antiretroviral Therapy in Naive HIV Infected AdultsCompletedNCT00820118Phase 2
• Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine TrialsTerminatedNCT00789789
• Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST)CompletedNCT00670839Phase 3
• Molecular Diversity of HIV-1 Group O Strains and Treatment Management in CameroonCompletedNCT00658346
• Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy VolunteersCompletedNCT00490074Phase 1/2
• Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected PatientsCompletedNCT00480792Phase 3
• Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 PrimevaCompletedNCT00424814Phase 2/3
• Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.CompletedNCT00323804Phase 2/3
• Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis CCompletedNCT00265642Phase 3
• Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-infected Patients in Virological Failure.CompletedNCT00196625Phase 2
• Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAARTCompletedNCT00196612Phase 3
• Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected AdultsCompletedNCT00196599Phase 2
• Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) CoinfectionTerminatedNCT00158535Phase 2
• Antibody Responses to Pneumococcal Vaccines Among HIV-infected Adults.CompletedNCT00148824Phase 2
• Trial for Hepatocellular Carcinoma Adjuvant Treatment by LipiocisCompletedNCT00116454Phase 3

← ANRS, Emerging Infectious Diseases overview and focus areas